Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Microsoft
MSFT
|
+$725M |
| 3 |
Apple
AAPL
|
+$628M |
| 4 |
Amazon
AMZN
|
+$487M |
| 5 |
Meta Platforms (Facebook)
META
|
+$355M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$121M |
| 2 |
KE Holdings
BEKE
|
+$31.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$24.4M |
| 4 |
X
US Steel
X
|
+$18.4M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$15.6M |
Sector Composition
| 1 | Technology | 34.97% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Communication Services | 10.31% |
| 4 | Healthcare | 9.95% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Digi International
DGII
$1.33B
| $2.46M | ﹤0.01% |
70,500
-1,100
| -2% | -$38.3K |
|
1677
Schrodinger
SDGR
$1.37B
| $2.45M | ﹤0.01% |
122,000
-1,300
| -1% | -$26.2K |
|
1678
Kaiser Aluminum
KALU
$1.24B
| $2.45M | ﹤0.01% |
30,700
-500
| -2% | -$40K |
|
1679
Planet Labs
PL
$3.01B
| $2.45M | ﹤0.01% |
401,700
| – | – |
|
1680
Flywire
FLYW
$1.63B
| $2.45M | ﹤0.01% |
209,200
-4,400
| -2% | -$51.5K |
|
1681
Alphatec Holdings
ATEC
$2.26B
| $2.44M | ﹤0.01% |
220,200
+13,000
| +6% | +$144K |
|
|
ARI
1682
Apollo Commercial Real Estate
ARI
$1.51B
| $2.44M | ﹤0.01% |
252,039
-2,300
| -0.9% | -$22.3K |
|
1683
NextDecade
NEXT
$1.79B
| $2.44M | ﹤0.01% |
273,800
-3,500
| -1% | -$31.2K |
|
1684
CRA International
CRAI
$1.3B
| $2.44M | ﹤0.01% |
13,000
-100
| -0.8% | -$18.7K |
|
|
XHR
1685
Xenia Hotels & Resorts
XHR
$1.41B
| $2.43M | ﹤0.01% |
193,680
-3,500
| -2% | -$44K |
|
1686
Amneal Pharmaceuticals
AMRX
$3.14B
| $2.42M | ﹤0.01% |
299,400
+29,300
| +11% | +$237K |
|
1687
TriCo Bancshares
TCBK
$1.48B
| $2.42M | ﹤0.01% |
59,800
-1,000
| -2% | -$40.5K |
|
1688
Weis Markets
WMK
$1.75B
| $2.42M | ﹤0.01% |
33,400
-500
| -1% | -$36.2K |
|
1689
Azenta
AZTA
$1.36B
| $2.42M | ﹤0.01% |
78,500
-1,200
| -2% | -$36.9K |
|
1690
TeraWulf
WULF
$4.39B
| $2.41M | ﹤0.01% |
549,700
-14,600
| -3% | -$63.9K |
|
1691
IMAX
IMAX
$1.74B
| $2.41M | ﹤0.01% |
86,100
-1,200
| -1% | -$33.6K |
|
1692
Andersons Inc
ANDE
$1.38B
| $2.4M | ﹤0.01% |
65,250
+2,500
| +4% | +$91.9K |
|
1693
Brookdale Senior Living
BKD
$1.78B
| $2.4M | ﹤0.01% |
344,239
-24,200
| -7% | -$168K |
|
1694
Baytex Energy
BTE
$1.83B
| $2.39M | ﹤0.01% |
1,339,488
-41,900
| -3% | -$74.8K |
|
1695
Alpha Metallurgical Resources
AMR
$1.87B
| $2.38M | ﹤0.01% |
21,200
-200
| -0.9% | -$22.5K |
|
1696
Travere Therapeutics
TVTX
$2.09B
| $2.38M | ﹤0.01% |
161,100
+3,000
| +2% | +$44.4K |
|
|
VRE
1697
Veris Residential
VRE
$1.49B
| $2.38M | ﹤0.01% |
159,800
-2,200
| -1% | -$32.8K |
|
1698
Lionsgate Studios Corp.
LION
$2.13B
| $2.38M | ﹤0.01% |
+409,098
| New | +$2.38M |
|
1699
Tandem Diabetes Care
TNDM
$829M
| $2.37M | ﹤0.01% |
127,300
| – | – |
|
1700
NovaGold Resources
NG
$2.82B
| $2.36M | ﹤0.01% |
576,700
+87,500
| +18% | +$358K |
|